Percutaneous absorption of dexamet hasone a nd its effect on t he pituitary ad renal a xis were measured in vivo in norm al human subjects afte r a ppli cation to skin . Specific plas ma dexamethasone and corti sol radioimmunoassays were used . Followin g application of 1 ~ dexamet.hasone on 500 em 2 of normal skin , the pla sma dexamet.hasone conce ntration was maximal at 2 hr. a nd the average absorption was O.25 g( over 8 hr ; sign ificant cortisol su ppression occurred at 2. 4. and 8 hr. This technique: (1) provides an accu rate assessment of the in vivo absorpti on of dexamet.hasone applied to human skin. (2, avoids exposure of the subjects to radioac t ive steroids. (3) perm it.s estimation of t he Quantity of unmetabolized steroids absorbed. and (4) serves as a possible model for the development of similar assays for other topical steroids.
Altbough there a re limited data on the quantity and patt.ern of t hei r abso rpt.ion, topical corti costeroids enjoy widespread use in clinical medici ne. Previous stud ies of t.opi cal absorption utilized in vitro skin prepa rat ions Ill. topically applied radioactively labeled corti costeroids 12-41. and physi ologic changes 15-6/. These studies were limited by the inability to d irectl y measure plasma leve ls of the applied steroid.
The objective of thi s study was to use specific radioimmu noassays t.o Quantitate the percutaneous absorption of dexamethasone and to det.ermine the effect of the absorbed dexamethasone on the adrenal-pituitary axis.
MATERIALS ASD METHODS
Three normal males and one normal female. ag-es 22 to 28. pa rticipated in the stud y and se rved as their ov.'Tl con trols. Three days before the dexametha sone study, baseline plasma cort isol conce ntrations were determ ined from samples drawn at O. L 4. 1 2 • 1, 2. 4. and 8 hr. beginnin g at 8 AM. T o insure initial uniform hydratio n on t he days that dexamethasone was applied. the applies -M anuscrip t received Septem ber 9, 1975 tion sites on the subjects' bacb were occluded with plastic film fo r 1 hr . After the occlusive wrap was removed. the excess moisLU re was patted dry with a paper towel and 1 ml of a standa rd solu t.i on of 10/, dexametha · sone in acetone was applied per 100 em ' (100 JJg /c m 7 ) . A si ngle ap pl ica ti on of the 11ft dexametha sone solution wa s made at weekly intervals on areas of 100. 200. and 500 em' in th e same Breas on each subjec t. The dexametha· sone was applied wi th a mechanical pipett e (Selec· l apette) and a " T " shaped glass rod was w:;ed to distribute the solution evenly. The acetone evaporated rapidly. lea ving a light coat of white crystals on the ski n . Foll owing the application of the dexametha!'One. the application sites were not re ·occludcd and there were no efforts to guard them . Blood was co lle cted al the same times as in the control period a nd wa s assayed for dexamethasone and cort isol.
One week afte r the last topical stud y. the distribution and plasma kinetics of dexamethasone were determined by injecting 1.2 mg of dexamethasone phosphate (I mg of dexamethasone) intravenously at 8 AM and obtaining serial plasma samples at I,I b. I ~, 1 2 • I. 2. 4. 6. a nd 8 hr. T he lwo·companment model ofTait et 81 [7] was u!o;ed to calculate the metaboli c clearance rale (Me R), the plasma half time rr . . . . ) of elim ination. and the volumes of di str ibution VIa nd V 2' The fra ction of dexamethasone a bsorbed percutaneou sly was ca lculated usi ng th e foll ow. ing formul a :
Percent absorbed /8 hr ;.
,01. 100 dose applied (mg) (lADC ~ int.egrated average dexamethasone concentra· tion) .
Specific antisera were prepared fo r dexamet hasone and corti sol by imm un izi ng rabbits with steroi d ·bovine seru m albumi n conjugates. T he methodology of the deve lopme nt of the assays has been described previously IS-tO). The dex amethasone assay has a sensitivity of 10 pg/assay tube and is specific for unmetabolized dexa· m elhasone (to I. Of the known endogenous steroids. only cortisol cross· reacted signifi ca ntly , O .4~. Because of this cross reaction, a smaJI amount of radioacti ve dexamethasone was added to each sample as an internal recovery standard, and the dexamethasone was isolated by paper chromatography before being assayed lID) . AU va.lues were corrected for the losses in herent in the extraction and chromatography procedures.
RESULTS
After application of 1 ml of 1 % dexamethasone to 100 crn 2 , the plasma dexamethasone levels were less than 20 ng/dl, and after application of 2.5 ml to 250 cm' they were from 20-40 ng/dJ. Accordingly, the corresponding plasma cortisol levels were not suppressed (Fig. I) .
The mean peak plasma dexamethasone concentration, following application of 5 ml of 1 % dexamethasone on 500 cm " was 250 ± 90 ng/ dl and occurred at about 2 hI. This decreased over the next 6 hr to 90 ng/ dl (Fig. 2) . Figure 1 shows the average plasma cortisol levels during the control period and the values after application of 1% dexamethasone on 100, 250, and 500 em'. Although the initial cortisol levels of the control were higher than expected! they were reproducible. Further, the values of the lOO·cm' and 250-cm2 experiments reveal that all the zeTO time values aTe closely grouped. There was n o significant difference between the cortisol values for the four trials at times 0, J 4 , J 2 , and 1 hr. Cortisol suppression was significant (p < 0.05, paired t-test ) at 2.4, and 8 hr after application of 1 % dexamethasone on 500 em 2 , The Table summarizes age \'alues for the plasma T " . metabo lic clearance rate, and the percentage absorbed over 8 hr.
DISCUSSION
Using specific radioimmunoassa ys. it was possible to quantitate the percentage of unrnetabolized dexamethasone absorbed , the a bsorption pattern of dexamethasone through normal human skin in vivo, and the effect of dexamethasone absorption on the pituitary-adrenal axis.
Alt.hough the initial hydration of the skin was constant, considerable absorption variation was noted among subjects. This is consistent with previous sl.udies 12-3 J and implies that the effective dosage range may vary greatly among patients.
Our data corroborate the study of Feldman and Maibach [2J. who applied 4 Jl g/ cm' of " C-Iabeled dexamethasone to 98 cm' on the fo rearms of normal volunteers and measured the excretion of radioactivity in the urine . They found that the radioactivity of the urine was maximal in the first 12 hr, 0.096% of the applied dose . Apparent differ· ences in absorption (0.25%/8 hr in this study vs 0.096%/12 hr) may result from differences in proce· dures and characteristics of the respective assays. By preoccluding the application areas, the hydra . tion of the skin was increased , possibly allowing for a more rapid and increased absorption. Theoretically. if the preocclusion had significantly affected the Smount and pattern of absorption. we would expect to see a more uniform response. Some of these apparent discrepancies might also be explained by differences in experimentsl techniques used to quantitate absorption . With our assay we were able to determine plasma levels of the unmetabolized dexamethasone at specified frequent intervals. The measurement of radioactivi ty of the urine using the techniques described by Feldman and Maibach 1 3J d id not specifically measure unrnetabolized dexame thasone .
Following large doses of topical corticosteroids to normal unoccluded skin, minimal effects on cortisol secretion have been observed IB]. Using specific radioimmunoassays and applying 50 mg of dexamethasone to normal skin , we were able to correlate dexamethasone and cortisol le ve ls and show suppression at 2. 4. and 8 hr . In previous Hudies. 24-hr urinary 17-0H co rt icosteroids were meas ured after the administrat ion of t opical cor ticosteroids ; consequently. transient suppressive ef· fects may have been undetected . We would expect greater absorption with diseased skin. along with a co rresponding increase in suppression of the pituitary-adrenal axis [6] [7] [8] [9] [10] [11] .
No sa mples were collected prior to 15 min and although the lowe r limit of the assay is 25 ng/ d!. the value at 15 min implies a small amou nt of Vol. 66, No.6 absorption . Subsequent to this time more rapid absorption is seen.
The advantages of a plasma assay that is both sensitive and specific are obvious. The technique described provides an accurate assessment of the in vivo absorption of dexamethasone applied to human skin . It does not require exposure of the subjects to radioactive steroids, it permits est.imation of the quantity of unmetabolized steroids absorbed, and it is a model for the development of similar assays using other topical steroids.
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